Cambridge Security Seals Launches A-MVB™ Line of Tamper-Evident Seals Equipped to Combat the Spread of Viruses and Diseases
July 08, 2020 09:20 ET | Cambridge Security Seals
Pomona, New York, July 08, 2020 (GLOBE NEWSWIRE) -- Cambridge Security Seals (CSS), a global leader in tamper-evident seals and security solutions, today unveiled its A-MVB™ line of antimicrobial,...
C-Bond Systems Announces Exclusive Nationwide Distribution Agreement for EPA Registered Disinfectant MB-10 Tablets Approved for Use Against Human Coronavirus SARS-CoV-2
June 01, 2020 08:31 ET | C-Bond Systems
HOUSTON, June 01, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems, Inc. (“C-Bond”) (OTC: CBNT), a nanotechnology solutions company, announced today that it has entered into an exclusive, nationwide...
ARCA biopharma Announces AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy
May 28, 2020 08:00 ET | ARCA biopharma, Inc.
AB201 (rNAPc2) is being developed as a potential treatment for COVID Associated Coagulopathy, a condition characterized by abnormal blood clotting in patients with COVID-19Previous safety data in more...
Atriva Therapeutics to Develop ATR-002 for Treatment of Patients with COVID-19 in Phase II Study
May 28, 2020 03:00 ET | Atriva Therapeutics GmbH
ATR-002 mode of action inhibits SARS-CoV-2 viral propagation and prevents the cytokine storm as demonstrated in preclinical studiesAtriva’s lead product candidate is the only host-targeted antiviral...
C-Bond Systems’ Manufacturing Facility Receives EPA Registration
April 30, 2020 08:31 ET | C-Bond Systems
HOUSTON, April 30, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems, Inc. (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, today announced its manufacturing facility has received...
C-Bond Systems Partners with THOMS Aviation, THOMS Automotive, and EXEGi Trading Company in Joint Marketing and Distribution Agreements to Expand its Nano Products Portfolio
March 30, 2020 08:31 ET | C-Bond Systems
THOMS Aviation and Automotive Products include Antibacterial and Antiviral Protection for Covid-19 and Other Pathogens THOMS’ Current Customers Include Transavia, KLM Cityhopper and EasyJet HOUSTON,...
Business Capital Delivers $5.5 Million Financing for Wedderspoon
January 14, 2020 07:00 ET | Business Capital
SAN FRANCISCO, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Business Capital structured and delivered a $5.5MM  working capital facility for Wedderspoon, the largest seller of Manuka honey and its portfolio of...
2019 logo_150x35_jpg.jpg
Novan Further Expands its Proprietary Nitric Oxide Platform
October 18, 2019 08:30 ET | Novan, Inc.
A new product candidate, SB207, to target anti-viral opportunitiesPre-IND meeting anticipated in December 2019Development of SB207 to be focused on indications with unmet patient need, such as...
novan logo.jpg
Novan SB206 Phase 3 Molluscum Pivotal Program Update
July 11, 2019 08:15 ET | Novan, Inc.
More than 50 percent of total expected patients now enrolledVirtually all of the clinical sites now active Discipline and execution focus remain of equal importance to recruitment activity ...
CidaraLogo (1).jpg
Cidara Provides Corporate Update and Reports First Quarter 2019 Financial Results
May 09, 2019 16:13 ET | Cidara Therapeutics, Inc.
SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...